Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Isis earns milestone for Macugen NDA filing

July 1, 2004

Statins a potential therapeutic option in glaucoma

June 29, 2004

Istalol NDA for glaucoma approved

June 9, 2004

Tosufloxacin tosilate eye drops submitted for Japanese approval

June 9, 2004

SnET2 NDA accepted for priority review

June 4, 2004

Proposed financing at InSite to advance AzaSite development

June 4, 2004

Allergan and Kyorin sign Japanese agreement for Alphagan franchise

June 2, 2004

FDA sets date to discuss Macugen NDA

June 1, 2004

Allergan presents new prostaglandin analogues with utility as ocular hypotensive agents

May 28, 2004

NDA filing for Xibrom

May 27, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...